Comparison Acrivon Therapeutics (ACRV) with Competitors
Acrivon Therapeutics (ACRV) industry is Biotechnology.
Free Cash Flow Yield
ACRV-89.11%
Industry-1.75%
Upside-87.37%
P/E
ACRV-0.82
Industry-20.52
Upside+1969.58%
P/B
ACRV0.96
Industry5.15
Upside-81.29%